This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Chi Shung Brian To: Innovator in Adenovirus Purification
Introduction
Chi Shung Brian To is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of adenoviruses. His innovative methods have the potential to enhance the efficiency and safety of viral vector production.
Latest Patents
Chi Shung Brian To holds a patent for "Methods of adenovirus purification." This patent presents a comprehensive process for purifying virus particles, especially recombinant adenovirus vector particles. The process utilizes various techniques, including cell lysis, detergent-based precipitation, depth filtration, ultrafiltration, nuclease digestion, and chromatography. These methods work together to produce highly purified products with contaminating DNA levels consistently below detectable levels.
Career Highlights
Chi Shung Brian To is currently employed at Merck & Co., Inc., where he applies his expertise in biotechnology. His work focuses on developing advanced methods for virus purification, which are crucial for the production of safe and effective viral therapies. His contributions to the field have been recognized for their potential impact on medical research and treatment.
Collaborations
Chi Shung Brian To collaborates with esteemed colleagues, including John O Konz, Jr. and Ann L Lee. These partnerships enhance the research and development efforts at Merck & Co., Inc., fostering innovation in the biotechnology sector.
Conclusion
Chi Shung Brian To is a pioneering inventor whose work in adenovirus purification is shaping the future of biotechnology. His innovative methods and collaborations are paving the way for advancements in viral vector production and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
